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1. Introduction 
 
 5 
1.1. Preeclampsia 
 
1.1.1. Definition 
Preeclampsia (PE) is a pregnancy related disorder, characterized by raised blood pressure and 
signs of kidney damage. The onset of this condition is usually after 20 weeks of gestation.  
According to the American College of Obstetricians and Gynecologists (ACOG), the criteria for 
the diagnosis of PE include onset of a new episode of hypertension during pregnancy, 
characterized with persistent hypertension (systolic blood pressure ≥140 mmHg or diastolic blood 
pressure ≥90 mm Hg) and substantial proteinuria (>300mg/L/24 hours) (1). In case of absence of 
proteinuria or proteinuria below the diagnostic threshold, other diagnostic criteria are required. 
They include impaired liver function, new-onset thrombocytopenia, pulmonary edema, visual or 
cerebral disturbances or renal insufficiency (1). 
PE can progress to severe PE, which includes liver dysfunction, edema, pain, low platelet count 
as well as vascular and cerebral disturbances. Less than 1% of women with PE proceed to the 
most severe form, named eclampsia, which is characterized by eclamptic seizures (2). 
 
1.1.2. Epidemiology 
Hypertensive disorders of pregnancy (HDP) complicate up to 10% of all pregnancies. They 
include gestational hypertension, chronic hypertension, chronic hypertension superimposed with 
PE and PE. The later one affects about 3% of all pregnancies, making up a substantial part of 
HDP (3).  
PE/eclampsia is a major cause of maternal and fetal mortality and morbidity. The maternal death 
rate of eclampsia and preeclampsia is 0-1.8% in developed countries and as high as 14% in 
developing countries. Fetal mortality is estimated to be 13-30% (4). 
Women with a previous history of PE are at 7 times higher risk of developing the condition in 
following pregnancies (5). Other risk factors include: age over 40 years, first pregnancy 
(primapara), maternal obesity, maternal diabetes (type 1 or type 2), previous hypertension, 
coagulation disorders, systemic diseases, like systemic lupus erythematosus (SLE), kidney 
diseases and multiple pregnancy (6).  
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1.1.3. Etiology 
The etiology of PE remains unknown. One of the most accepted theories characterized PE as a 
multisystem disorder due to abnormal response of the maternal vasculature to placentation.  
In normal pregnancies, structural modifications of the spiral arteries by invasion of the 
cytotrophoblasts (CTB) causes them to be highly dilated and thus to become less resistant. This 
allows them to be less sensitive to vasoconstrictive substances. The described physiological 
change plays a vital role for the supply of nutrients to the placenta and eventually the foetus (7). 
 
In placentas from pregnancies complicated with PE, this remodelling process has failed and the 
remaining increased uterine arterial resistance is preserved or even increased. In addition, the 
preserved sensitivity to vasoconstrictive substances induces a condition of chronic placental 
ischemia and oxidative stress (8). 
 
Fetal complications develop as sequel to placental ischemia whereas maternal complications are 
caused by oxidative stress triggering the release of certain substances into the maternal 
circulation. These substances include free radicals, oxidized lipids, cytokines, and serum soluble 
vascular endothelial growth factor 1 (9). 
They are responsible for the vascular endothelial dysfunction seen in PE, including vascular 
hyperpermeability, thrombophilia and hypertension (8).  
Another mechanism contributing to the development of PE is a disturbed trophoblast life cycle. 
Changes in apoptosis, meaning programmed cell death of the trophoblast, is thought to be one of 
the core factors for evoking an inflammatory response from the mother, as seen in PE. The 
normal trophoblast lifecycle, which is approximately 25 days long (10), includes differentiation 
and proliferation of mononucleated CTB with eventual fusion into multinucleated 
syncytiotrophoblasts, followed by the formation of syncytial knots. Those syncytial knots 
represent dying remnants of the trophoblast and they are finally shed from the surface of villi into 
the maternal circulation, where maternal pulmonary macrophages eliminate them. The described 
process is also known as trophoblast turnover (11). 
In PE however, several studies revealed an imbalance between proapoptotic and antiapoptotic 
factors and therefore an increased apoptosis, which is believed to be crucial in the development 
of PE (11,12). In this context, aponecrosis, meaning incomplete apoptosis and eventual necrosis 
with formation of impaired syncytial knots, is another important parameter. Compared to 
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apoptosis with normal formation of syncytial knots, those produced from aponecrosis are still 
capable of evoking an inflammatory response from the mother (13).  
  
PE is a disorder with a high risk of progression to more severe conditions like eclampsia, which 
includes convulsions. The risk of developing cardiovascular disorders and chronic kidney disease 
due to metabolic stresses and vascular injury induced by PE is increased. In case of severe PE, 
the clinical findings despite hypertension and proteinuria also include signs of microangiopathy, 
systemic endothelial dysfunction and the HELLP syndrome (haemolysis, low platelet count and 
elevated liver function tests) (14).  
Other symptoms include swelling, shortness of breath and visual disturbances. Preterm delivery, 
placental abruption, caesarean delivery and even stillbirth show an increased occurrence in 
pregnancies complicated with PE. The need for preterm delivery, as only known cure for PE, 
poses a risk for the neonatal wellbeing. Late preterm neonates appear to have a significantly 
higher mortality rate than term infants (15-19). 
The decreased uteroplacental blood flow during pregnancy and the resulting ischemia increases 
the risk for the foetus to develop intrauterine growth retardation. Neonatal thrombocytopenia, 
increased risk for neutropenia, bronchopulmonary dysplasia and variable neurodevelopmental 
outcomes are further complications for the neonate (20). 
 
1.2. Placenta 
 
1.2.1. Development of placenta and its role in normal pregnancy 
Six days after fertilization, the blastocyst attaches to the endometrium. The trophoblast, which is 
the outer layer of the blastocyst, proliferates and differentiates into the outer syncytiotrophoblast 
(STB) and the inner CTB to enable the implantation of the embryo. The CTB give rise to 
amnioblasts, which eventually form the amnion. The STB on the other hand, invade the 
endometrium and form lacunae, which become filled with maternal blood. Primitive intervillous 
spaces form by fusion of several lacunae. Primitive villi develop from CTB proliferation. The 
chorion is formed by extraembrionic mesoderm and the primitive villi.  Chorionic villi, which are 
in contact with the maternal blood in the lacunae develop from the villous trophoblast (VTB). 
The chorionic plate is build by rapidly proliferating villi along the decidua basalis. Extravillous 
trophoblast (EVTB) that is formed by CTB in the tips of villi, penetrate the maternal vessels and 
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help to anchor the placenta. Besides, EVTB is further classified into interstitial and the 
endovascular trophoblast. The later is responsible for the remodeling of the spiral arteries shortly 
after implantation. This process is crucial in the development of the placenta. It ensures the high 
flow, low resistance uteroplacental vasculature in the normal placenta. The remodelling of spiral 
arteries by endovascular trophoblast has two peaks in time. The first one is around 8 to 10 weeks 
of gestation and involves the invasion into decidual segments of spiral arteries. At 16 to 18 weeks 
of gestation the second peak occurs with invasion into myometrial segments. This mechanism 
ensures gradual loss of spiral artery musculature and replacement with fibrinoid material to 
enable a successful pregnancy (21). 
Umbilical vessels formed by the mesoderm in the core of the villi, the allantois and remnants of 
the yolk sac build up the umbilical cord. In the end there is a fusion of amnion and chorion to 
form the amniochorionic membrane, which eventually fuses with the decidua capsularis and the 
decidua parietalis as the embryo grows (22,24).  
The placenta is fully functional by the end of the third month of gestation. Its role is to provide 
nutrients and oxygen for the foetus as well as to eliminate waste products. Furthermore it has an 
immunologic role, as IgG antibodies may pass to provide passive immunity for the foetus. It also 
serves as endocrine organ, secreting human chorionic gonadotropin to ensure that the pregnancy 
may take place as well as a set of different other hormones. Since the placenta carries much more 
blood than actually needed by the foetus, it also has a compensatory function in case of 
diminished blood flow (25). 
When fully developed, on gross examination, the placenta is composed of the placental disk, 
extraplacental membranes and the umbilical cord (Figure 1).  
 
 
 
 9 
 
 
Figure 1. Gross image of term placenta. A. Maternal side of the term placenta. B. Foetal side of 
the placenta with the umbilical cord. (Images taken from the personal archive of the mentor with 
mentor’s permission). 
 
 
 
Cotyledons and the basal plate can be found on the maternal side of the placental disk, whereas 
foetal side, which is covered with the amnion, is called chorionic plate. The later is the place for 
umbilical cord insertion. Extraplacental membranes are usually attached to placental disk margins 
(23).  
Microscopically, the basal plate includes decidua basalis, EVTB and maternal blood vessels. The 
chorionic plate is composed of subchorionic fibrin, umbilical blood vessel branches, chorion and 
amnion. In between basal and chorionic plate, stem, intermediate and terminal villi as well as 
intervillous spaces are seen, building the placental parenchyma. Septa, made out of EVTB are 
subdividing the basal plate into cotyledons. The membranes consist of amniotic epithelium, 
connective tissue and chorion, which is composed of EVTB and involuted villi, attached decidua 
parietalis and capsularis as well as maternal blood vessels and yolk sac remnants (Figure 2). 
Finally, the umbilical cord is made of two arteries, one vein, Wharton’s jelly and surface 
epithelium (23). 
 
A B 
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Figure 2. Histology of term placenta with placental villi, syncytial knots and intervillous spaces 
with maternal blood (Hematoxylin&Eosin, magnification 100x, Olympus BX41 microscope; 
image taken by candidate at the Pathology Department).  
 
 
 
1.2.2. Placenta in preeclampsia 
Abnormalities in the placenta are believed to be the major components in the PE development. 
Diminished blood flow through the placenta due to defects in the maternal vasculature to adapt to 
normal pregnancy is the core pathological feature of PE. At about 10 weeks of gestation, the 
intervillous space becomes vascularized and CTB undergoes changes to respond to the previous 
low oxygen environment. The differentiation into the invasive trophoblast phenotypes allows the 
spiral arteries to be modified into flaccid, funnel shaped large diameter vessels, which are 
insensitive to humoral or neural vasoconstrictive substances. In PE however, these vessels remain 
contractile and cause a large amount of oxidative stress. Acute atherosis, the occlusion of vessels 
by fibrinoid surrounded by foam cells, is another change seen microscopically in the unmodified 
spiral arteries, contributing to the state of underperfusion (Figure 3) (26,27). 
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Figure 3. Acute atherosis of blood vessels in the decidua basalis from placenta with preeclampsia 
(Hematoxylin&Eosin, magnification 100x, Olympus BX41 microscope; image taken from the 
personal archive of the mentor with the mentor’s permission) 
 
 
Histologically, numerous large syncytial knots, small sclerotic villi and accelerated villous 
branching are seen due to hypoxia and resulting reactive oxygen species. Especially in severe PE, 
also gross morphological changes like infarctions and abnormal placental shape might be noted. 
Despite some characteristic changes in placentas of pregnancies complicated with PE, the exact 
linkage between abnormal throphoblast invasion and the maternal disease remains unknown 
(26,27).  
 
1.2.3. Multinucleated Giant Cells 
Multinucleated Giant Cells (MGC) constitute a subgroup of EVTB near the site of implantation, 
which have lost their invasive properties (28,29). Their trophoblastic origin was confirmed by 
immunohistochemical labelling and observation with a light microscope by Pijnenborg et al. as 
well as Wells and Bulmer (30,31). 
MGCs appear to be larger than the surrounding trophoblast and contain two or more nuclei, 
which is probably attributed to cell fusion (Figure 4). 
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Figure 4. Multinucleated giant cells (MGC) in the decidua basalis from placenta with 
preeclampsia (Hematoxylin&Eosin, magnification 400x, Olympus BX41 microscope; image 
taken by candidate at the Pathology Department).  
 
 
MGC mostly appear in mid pregnancy but they can also be seen later (28). 
Usually MGCs can be found as a normal component of the implantation site but they appear to be 
increased in placentas of pregnancies complicated by PE and decreased in placenta creta (32-35).  
Hence, they are not merely a characteristic of maternal vascular underperfusion in PE but also 
linked to other types of pregnancy related disorders associated with placental hypoxia. Their 
significance lies in being very specific and therefore MGC might be used to retrospectively 
clarify perinatal mortality and morbidity, meaning when seen in excess number in placentas from 
full term pregnancies, they could be indicative of pre-existing hypoxia (29). 
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2. Hypothesis 
 
 14 
Placentas from pregnancies complicated with PE show an increased number of MGC in the 
decidua basalis compared to placentas from normal pregnancies. 
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3. Material and Methods 
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The study was conducted upon approval of the local Ethics Committee and after all participants 
provided informed consent. 
Overall this study included 30 placentas. 
The studied group was represented by 15 placentas from singleton term pregnancies complicated 
with PE, which was diagnosed based on following criteria: systolic blood pressure >140 mmHg 
and diastolic blood pressure >90 mmHg; proteinuria >300 mg/L per 24 hours (1). 
The remaining 15 placentas were collected from singleton term pregnancies without clinical signs 
of PE and posed the control group. 
General exclusion criteria for both groups were: diagnosis of HELLP syndrome (platelets 
<100x10
9
/L, AST and ALT >70 U/L, and LDH >600 U/L) (14), renal diseases, vascular diseases 
like hypertension, or any other maternal condition existing prior to pregnancy. 
 
Within 20 minutes after delivery, placentas were collected from the delivery room of the 
University Hospital of Split, fixed in 4% buffered formalin and sent to the Pathology Department 
for further evaluation.  
Placental samples, all containing decidua basalis, were taken from the macroscopically normal 
part of the placental disk, near to the umbilical cord insertion site. Sections of 4-μm thickness 
were cut from previously paraffin embedded placental samples. Afterward they were mounted on 
silanized slides and dried at 37°C. After hematoxylin and eosin staining, histologic examination 
was performed using an Olympus BX 41 microscope (Olympus, Tokyo, Japan). 
 
Immunohistochemistry was done after the paraffin slices were mounted on super frost slides 
(Thermoscientific, Darmstadt, Germany) and further processed in the automatic stainer (Ventana 
Bench Mark Ultra autostainer, Tucson, USA). CK7 antibody (rabbit monoclonal antibody, clone 
SP52, Ventana, Tucson, USA) was used to distinguish EVTB from decidual cells (DC) in the 
decidua basalis with Ultra view Universal DAB detection kit (Ventana, Tucson, USA). DC were 
CK7 negative whereas EVTB cells were CK7 positive. 
Since MGC are considered to be EVTB, they were also CK7 positive (Figure 5). 
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Figure 5. Immunohistochemical staining with CK7, brown membranous and cytoplasmic 
staining of extravillous trophoblast (EVTB) and multinucleated giant cells (MGC, marked with 
red circle). Decidual cells (DC) are negative (blue arrows). (Magnification 400x, Olympus BX41 
microscope; image taken by candidate at the Pathology Department).  
 
 
For each sample, the number of MGC, EVTB and DC in the decidua basalis was determined by 
the use of Olympus BX 41 microscope and Olympus cell D1 image analyser.  
Statistical analysis was done by the MedCalc software (MedCalc softare, Mariakerke, Belgium) 
using the chi-square-test, t-test for independent samples and Mann-Whitney test, depending on 
the result distribution. Statistical significance was set at p < 0.05. Results were expressed as mean 
with standard deviation or median with minimum and maximum value, depending on the result 
distribution determined by Kolmogorov-Smirnov test.  
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4. Results 
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Fifteen placentas from PE were included in the studied group and the same number of placentas 
from normal pregnancies in the control group. There was no statistically significant difference 
regarding maternal age (p=0.390; t=0.872; DF=27), gestational age (p=0.644; t=0.468; DF=28), 
birth weight (p=0.657; t=0.449; DF=28) and neonatal gender (p=0.695; χ2 = 0.153; DF=1) 
between investigated groups (Table 1). 
 
There was no statistically significant difference in the number of DC and EVTB between both 
groups (p=0.112; t=1.643; DF=28); (p=0.115; Z=3.846) as well as in MGC/EVTB ratio (p=0.113; 
Z=1.587) (Table 2). 
The number of MGC was significantly higher in the PE group compared to control group 
(p<0.001; Z=3.765). Likewise MGC/DC ratio was significantly higher in the PE group compared 
to control (p<0.001; Z=1.587) (Table 2). 
 
 
Table 1. Age of participants, gestational age at birth as well as birth weight and gender of the 
neonate 
 PE group 
(N=15) 
Control group 
(N=15) 
p 
Age of the mother 
(years) 
34 ± 7.14 31 ± 7.86 0.390* 
Gestational age (weeks) 38 ± 1.36 38 ± 0.94 0.644* 
Birth weight (grams) 3304±971.88 3429±462.34 0.657* 
Gender (male sex) 11 10 0.695† 
*Student t-test 
†chi-square tests 
The values are presented as arithmetic mean ± standard deviation or general number. 
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Table 2. The number of multinucleated giant cells (MGC), decidual cells (DC) and 
extravillous trophoblast (EVTB) as well as the ratio between MGC and DC and MGC and 
EVTB  
 PE group 
(N=15) 
Control group 
(N=15) 
p 
MGC 3 (0-15) 0 (0-4) <0.001* 
DC 205.46  ± 227.64 325.46± 167.95 0.112† 
EVTB 880 (153-2290) 420 (61-2438) 0.115* 
MGC/DC 0.03 (0-14) 0 (0-0.01) <0.001* 
MGC/EVTB 0 (0-0.04) 0 (0-0.02) 0.113* 
*Mann-Whitney U test 
† Student t-test 
The values are presented as median with minimum and maximum values or as arithmetic mean ± 
standard deviation. 
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5. Discussion 
 
 22 
PE is a very heterogeneous condition with many influencing factors and a still unknown etiology. 
Many of those factors are being investigated to show their interference with normal placental 
development. This study aimed to show the number of placental MGC in the decidua basalis 
from PE placentas and to compare the results with MGC number in placentas from normal 
pregnancies.  
 
Results of this study have shown that there is a significant difference in the number of MGC in 
PE placentas compared to the control group, MGC being higher in the studied group. 
To the best of my knowledge, it is the first study to investigate the number of MGC in the 
decidua basalis from PE pregnancies solely and to compare them with the results from normal 
placentas. 
 
MGC can also be found in normal pregnancies, especially in mid pregnancy (28). Their function 
is largely unknown. It is thought that they are created from EVTB by cell fusion (29-31). 
A significant increase of MGC in the studied group suggests that MGC formation is being 
triggered by a hypoxic injury pattern. There are many different placental responses to hypoxia. 
Not only the duration of hypoxia plays a role, but also whether it is a preuterine, uterine or 
postuterine pattern of hypoxia as Stanek pointed out (36). He described that MGC in the decidua 
basalis, as well as excessive EVTB numbers are less commonly seen in preuterine pattern of 
chronic placental hypoxia (e.g. maternal anemia). Also, he emphasized that this pattern has a 
better prognosis than other types of placental hypoxia and concluded that it is most probably due 
to hypoxic preconditioning. This implies that the specific hypoxic injury pattern plays a major 
role in the production of MGC. Hence, they are not increased in all hypoxic patterns, which 
makes them relatively specific for certain types of hypoxia, as for chronic uterine hypoxic pattern 
seen in PE (36). Still it is not clear, if there are other factors being involved, which might trigger 
the development of MGC in conditions like PE.  
 
Cowden Dahl et al. discuss hypoxia-induced changes on molecular level that might be involved 
in MGC production (37). Especially hypoxia-inducible factors (HIFs) seem to be included in 
giant cell formation and differentiation (37). This means, that although hypoxia might be the 
main mechanism to trigger MGC production, many different pathways on molecular level seem 
to be of importance for the formation of MGC. 
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Stanek et al. reported a significantly increased number of MGC, not only in PE, but also in other 
high-risk pregnancies associated with this chronic uterine hypoxic injury pattern. These findings 
suggested the high value of MGC in explaining perinatal mortality and morbidity (29), because it 
might function as indicator for hypoxia. 
 
The number of MGC was likewise found to be significantly higher in placenta previas by Biswas 
et al. (38), which might also be explained by hypoxia due to bleeding, inadequate attachment or 
changes in spiral arterioles, and therefore placental malperfusion. This would support the theory 
that placental hypoxia is the main trigger for MGC increase. Van Beekhuizen et al. on the other 
hand, reported a decreased number of MGC in retained placentas (placenta adhesiva) and 
concluded that the missing fusion of trophoblasts and hence the decreased number of MGC might 
be a factor involved in the pathology of placenta adhesiva (39). This finding implies, that MGC 
play a role in the regulation of placental adhesion and are needed in order to prevent the event of 
retained placenta whereas their abundance is a sign of placental hypoxia. 
 
As Stanek et al. pointed out, MGC measurement could be used retrospectively to explain adverse 
pregnancy outcomes (29). Since the number of MGCs is also elevated in other pregnancy related 
complications than PE, it is not specific for this condition (38). Also it is not clear whether MGCs 
contribute to the development of PE or are they just an indicator of placental hypoxia. 
 
Moreover this study showed a significant increase in the MGC/DC ratio in the studied group 
compared to control, but there was no statistically significant difference in the number of DC and 
EVTB between both groups, meaning that the number of DC and EVTB did not have any 
influence on the increased number of MGC. 
 
This study was limited by a relatively small sample size (N=15 in each group). Also, it was 
difficult to distinguish between EVTB and DC on the basis of standard hemalaun and eosin 
(H&E) slides, so CK7 antibody staining was introduced to avoid possible errors. 
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6. Conclusion 
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Concluding, this study suggests that there is an increased number of MGC in the decidua basalis 
in placentas from pregnancies with PE compare to placentas from normal pregnancies. This 
finding might be a useful marker in the workup of pregnancies that have been complicated by PE. 
The exact etiology of the formation of MGCs and possible contribution to the course of PE is yet 
to be determined. 
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8. Summary (English) 
 31 
MULTINUCLEATED GIANT EXTRAVILLOUS TROPHOBLAST CELLS IN THE 
DECIDUA OF PLACENTAS COMPLICATED WITH PREECLAMPSIA 
Objectives: To compare the number of Multinucleated Giant Cells (MGC) in the decidua basalis 
of placentas complicated with preeclampsia (PE) and placentas from normal pregnancies. 
Subject and Method: Fifteen placental samples from pregnancies complicated with PE and the 
same number of placental samples from normal pregnancies were taken. For each placental 
sample the number of MGC, extravillous trophoblast (EVTB) and decidual cells (DC) was 
counted in the decidua basalis. Immunohistochemistry with primary antibody CK7 was used to 
distinguish EVTB and MGC from DC. The MGC/DC ratio and MGC/EVTB ratio was also 
determined.  
Results: MGC number was significantly higher in placentas complicated with PE. Likewise 
MGC/DC ratio was found to be significantly higher in the studied group. There was no 
statistically significant difference in EVTB and DC number as well as MGC/EVTB ratio. 
Conclusion: Increased MGC number in the decidua basalis could be a morphological sign of PE 
and hypoxic conditions in the placenta. 
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9. Summary (Croatian) 
 33 
MULTINUKLEARNE ORIJAŠKE STANICE EKSTRAVILOZNOG TROFOBLASTA U 
DECIDUI POSTELJICA IZ TRUDNOĆA S PREEKLAMPSIJOM 
Ciljevi: Usporediti broj multinuklearnih orijaških stanica (MOS) u decidui basalis posteljica iz 
trudnoća s preeklampsijom (PE) i posteljica iz normalnih trudnoća. 
Materijali i metode: U ispitivanu skupinu je uključeno petnaest uzoraka posteljica iz trudnoća s 
PE. Isti broj uzoraka posteljica iz normalnih trudnoća je činio kontrolnu skupinu. U svakom 
uzorku je određen broj MOSa, stanica ekstraviloznog trofoblasta (EVTB) i decidualnih stanica 
(DS) u decidui basalis. Za razlikovanje stanica EVTB i MOSa od DSa korišteno je 
imunohistokemijsko bojanje s primarnim protutijelom CK7. Određen je i odnos MOS/DS i 
MOS/EVTB.  
Rezultati: Broj MOS je bio značajno veći u ispitivanoj skupini posteljica u odnosu na kontrolnu 
skupinu. Odnos MOS/DS je također bio značajno veći u ispitivanoj skupini posteljica. Nije bilo 
statistički značajne razlike u broju stanica EVTB, DS kao i u odnosu MOS/EVTB između dvije 
skupine. 
Zaključak: Povišeni broj MOSa u decidui basalis jedan je od morfoloških znakova koji mogu 
ukazivati da se radi o pesteljici trudnoće s PE, to jest o postojanju hipoksičnih uvjeta.  
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